These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17943542

  • 1. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone.
    Patki A, Pawar VC.
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():68-72. PubMed ID: 17943542
    [Abstract] [Full Text] [Related]

  • 2. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [Abstract] [Full Text] [Related]

  • 3. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S.
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [Abstract] [Full Text] [Related]

  • 4. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V, Tomic J, Klaic DZ, Kasum M, Kuna K.
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [Abstract] [Full Text] [Related]

  • 5. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
    Ludwig M, Finas A, Katalinic A, Strik D, Kowalcek I, Schwartz P, Felberbaum R, Küpker W, Schöpper B, Al-Hasani S, Diedrich K.
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J, Luteal Phase Study Group.
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N, Zamaniyan M, Salehpour S, Zadehmodarres S, Hoseini S, Cheraghi L, Seif S, Baheiraei N.
    Gynecol Endocrinol; 2016 Jun; 32(3):213-7. PubMed ID: 26486011
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study.
    Iwase A, Ando H, Toda S, Ishimatsu S, Harata T, Kurotsuchi S, Shimomura Y, Goto M, Kikkawa F.
    Arch Gynecol Obstet; 2008 Apr; 277(4):319-24. PubMed ID: 17938943
    [Abstract] [Full Text] [Related]

  • 12. Comparison of oral dydrogesterone and vaginal micronized progesterone for luteal phase support in intrauterine insemination.
    Taş M, Uludag SZ, Aygen ME, Sahin Y.
    Gynecol Endocrinol; 2020 Jan; 36(1):77-80. PubMed ID: 31464143
    [Abstract] [Full Text] [Related]

  • 13. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S, Chattopadhyay R, Goswami S, Chaudhury K, Chakravarty B, Ganesh A.
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [Abstract] [Full Text] [Related]

  • 14. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
    Barbosa MW, Silva LR, Navarro PA, Ferriani RA, Nastri CO, Martins WP.
    Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
    [Abstract] [Full Text] [Related]

  • 15. An update of luteal phase support in stimulated IVF cycles.
    Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P.
    Hum Reprod Update; 2007 Aug; 13(6):581-90. PubMed ID: 17626114
    [Abstract] [Full Text] [Related]

  • 16. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, Garcia-Velasco JA.
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [Abstract] [Full Text] [Related]

  • 17. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P, Chun Cheung M, Ping Cheung L, Ingrid Lok H, John Haines C.
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients.
    Ozer G, Yuksel B, Yucel Cicek OS, Kahraman S.
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102030. PubMed ID: 33271319
    [Abstract] [Full Text] [Related]

  • 20. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ, Nulsen JC.
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.